Nuzenio

Theriva Biologics Doses

Theriva Biologics Doses news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.comclinicaltrialvanguard.com · Fri, 07 Aug 2026 06:44:00 GMT MetaVia’s DA-1726 Reaches Highest Doses in Phase 1 Study Ahead of 2026 Results - clinicaltrialvanguard.comclinicaltrialvanguard.com · Fri, 07 Aug 2026 06:39:00 GMT Theriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - MinichartMinichart · Thu, 06 Aug 2026 18:27:00 GMT Theriva Begins VIRAGE2 Trial in Metastatic Pancreatic Cancer - TipRanksTipRanks · Thu, 06 Aug 2026 12:41:42 GMT Theriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock TitanStock Titan · Thu, 06 Aug 2026 12:11:14 GMT Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 12:00:00 GMT

Timeline

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.com

Fri, 07 Aug 2026 06:39:00 GMTMetaVia’s DA-1726 Reaches Highest Doses in Phase 1 Study Ahead of 2026 Results - clinicaltrialvanguard.com

Thu, 06 Aug 2026 18:27:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Phase 2a Trial to Refine VCN-01 Therapy for Metastatic Pancreatic Cancer – Minichart - Minichart

Thu, 06 Aug 2026 12:41:42 GMTTheriva Begins VIRAGE2 Trial in Metastatic Pancreatic Cancer - TipRanks

Thu, 06 Aug 2026 12:11:14 GMTTheriva Biologics (NYSE American: TOVX) starts VIRAGE2 Phase 2a trial in PDAC - Stock Titan

Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock Titan

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Phase8 live mentions Trial6 live mentions Metastatic Pancreatic Cancer6 live mentions VCN4 live mentions First Patient3 live mentions Dosing3 live mentions MetaVia2 live mentions Reaches Highest Doses2 live mentions Study Ahead2 live mentions Results2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Theriva Biologics Doses.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.